Risk Management in the Midst of the Coronavirus Outbreak: What Do Companies Need to Know?
As the novel coronavirus (COVID-19) continues to spread, the domestic and international risks for U.S. companies continue to grow. So, what do you need to know in order to minimize the immediate and long-term effects on your company’s bottom line? As of March 1, 2020, there have been two confirmed...
Read moreHow CGX Laboratories Can Be Compliant
Medicare began providing coverage for genetic cancer screening (CGX) in 2018. While this was a positive development for testing laboratories, some labs that have been billing Medicare for CGX have run into compliance issues. If your testing laboratory bills Medicare for CGX, this article provides an overview of what you...
Read moreCBD Compliance for Pharmacists
More patients are coming to you every day asking about CBD oil and other cannabis-based treatments and medications. Here’s what you need to know in order to maintain federal compliance. When the federal Agriculture Improvement Act of 2018 (commonly known as the “Farm Bill”) was passed late last year, hemp...
Read moreAlzheimer’s Testing Compliance
According to the National Institutes of Health (NIH), it is estimated that more than 5.5 million Americans may suffer from Alzheimer’s disease. Among other things, this means that diagnosing and treating seniors with Alzheimer’s disease presents a significant opportunity for neurologists, psychiatrists, geriatricians, and other healthcare providers to help people...
Read moreContinuous Glucose Monitoring (CGM) Medicare Compliance
In 2018, the Centers for Medicare and Medicaid Services (CMS) expanded Medicare coverage for continuous glucose monitoring (CGM). While this is good news for program beneficiaries who need CGM, billing compliance has proven to be a challenge for many pharmacies and other healthcare providers. When continuous glucose monitoring (CGM) was...
Read moreMedicare Revalidation: What Do Healthcare Providers Need to Know?
All Medicare-participating healthcare providers and medical businesses are subject to revalidation. The revalidation process involves confirming the accuracy of the provider’s enrollment data (or making updates, if necessary), and it must be completed upon request from the Centers for Medicare and Medicaid Services (CMS). According to CMS: “Medicare providers must...
Read moreWhy DOL Providers Should Absolutely Have a Corporate Compliance Program
Former DOL Prosecutors and Experienced DOL/Workers Compensation Lawyers Protect Business Owners and Medical Providers Nationwide Oberheiden, P.C. is one of the few firms with substantial experience in the areas of federal workers compensation regulations. Attorney Dr. Nick Oberheiden and his team have advised DOL providers across the country how to...
Read moreDEA Registration Applications, Denials & Show Cause Hearings
Federal Defense Attorneys Assisting with DEA Application Denials In order to prescribe or dispense controlled substances as a healthcare provider in the United States, you must first register your practice, business, or facility with the U.S. Drug Enforcement Administration (DEA). DEA registrations also need to be renewed on an...
Read moreWhat Compound Pharmacies Should Do In A DOL Or Tricare Investigation
Dr. Nick Oberheiden, Esq. www.federal-lawyer.com 888-680-1745 Open on Weekends Almost no week goes by without publication of a new investigation against compound pharmacies. The focus of these investigations is the relationship between pharmacy executives, physicians, and marketing groups with respect to referrals of federally funded patients; in particular, the investigations...
Read more5 Fraud & Abuse Laws That Every Physician Should Know
Dr. Nick Oberheiden, Esq. www.federal-lawyer.com Direct: 888-680-1745 The purpose of this overview is raise awareness among physicians (or to remind them) of important laws that apply to their practice and underlying business transactions. Due to the constraints of this paper, a detailed account or legal analysis cannot be provided. For...
Read more